The In vitro Effect of Nanoliposomal Amphotericin B Against Rhizopus arrhizus Isolated From COVID-19-Associated Mucormycosis Patients
The study emphasized NLAmB's sustained activity, making it a potential alternative to LAmB. Further exploration and clinical correlation are warranted to validate NLAmB in CAM treatment.
Authors
- Sadegh Khodavaisy
- Ali Ahmadi (ORCID: https://orcid.org/0000-0001-7659-7059)
- Farzaneh Afshari
- Roshanak Daie Ghazvini (ORCID: https://orcid.org/0000-0001-5320-5323)
- Laura Alcázar‐Fuoli (ORCID: https://orcid.org/0000-0001-8910-6095)
- Mahmoud Reza Jaafari (ORCID: https://orcid.org/0000-0003-3908-6828)
- Jamileh Esmaeili
- Seyed Mahdi Rezayat (ORCID: https://orcid.org/0000-0001-5387-6688)
- Mohammad Abdollahı (ORCID: https://orcid.org/0000-0003-0123-1209)
- Sayed Jamal Hashemi
- Fatemeh Saiedmohammadi
Institutions
- Mashhad University of Medical Sciences (IR)
- Imam Khomeini Hospital (IR)
- Instituto de Salud Carlos III (ES)
- Universal Scientific Education and Research Network (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Iranian journal of pathology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.30699/ijp.2024.2033626.3320
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Tehran University of Medical Sciences and Health Services